1. |
Afanasieva EV. Assessment of health-related quality-of-life. Good Clinical Practice. 2010;1:56-58.
|
2. |
Novik AA, Ionova TP. Manual on studying quality of life in medicine. Under the editorship of Shevchenko Yu. P., member of Russian Academy of Medical Sciences. St. Petersburg. Moscow: “Neva” Publishing House; 2007.
|
3. |
Kind P, Williams A. Measuring success in health care – the time has come to do it properly. Health Policy Matter. 2004;9:1-8.
|
4. |
Krom IL, Erugina MV, Sazanova GY. Assessment of medical care in the context of quality of life in patients with ischemic heart disease. Fundamental Studies. 2015;1(6):1174-1177.
|
5. |
Shalnova SA, Konradi AO, Karpov YA, Kontzevaya AV, Deev AD, Kapustina AV. Analysis of mortality due to cardiovascular disease in 12 regions of the Russian Federation, participating in the study “Epidemiology of Cardiovascular Disease in Various Regions of Russia”. Russian Cardiological Journal. 2012;5:6-11.
|
6. |
Arnold SV, Kosiborod M, McGuire DK. Effects of ranolazine on quality of life among patients with diabetes mellitus and stable angina. JAMA Intern Med. 2014;174(8):1403. https://doi.org/10.1001/jamain....
|
7. |
Tendera M, Chassany O, Ferrari R. Quality of life with ivabradine in patients with angina pectoris. Circ Cardiovasc Qual Outcomes. 2016;9(1):31-8. https://doi.org/10.1161/CIRCOU....
|
8. |
Cardiovascular Prevention. National Guidelines. All-Russian Scientific Society of Cardiology. Cardiovascular Therapy and Prevention. 2011;6(2):57-64.
|
9. |
Montalescot G, Sechtem U. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949-3003. https://doi.org/10.1093/eurhea....
|
10. |
Secco GG, Parisi R, Mirabella F. Old and New Drugs for Treatment of Stable Angina: New Anti-Anginal Drugs and Coronary Revascularization. Cardiovasc Hematol Agents Med Chem. 2015;13(1):21-24. https://doi.org/10.2174/187152... PMid:25544117.
|
11. |
Egorov VA, Shilova EV, Martzevich SY. Choice of nitrates therapy in patients with stable angina pectoris: comparative study of ordinary tablets of isosorbide dinitrate and different dosage forms of isosorbide-5-mononitrate. Rational Pharmacotherapy in Cardiology. 2008;2:19-22.
|
12. |
Zhilyaev EV. Nitrates in treatment of stable angina: new horizons. Consilium Medicum. 2010;1:14-18.
|
13. |
Roland E. Safety profile of an anti-anginal agent with potassium channel opening activity: an overview. Europ. Heart J. 1993;14:40–47. https://doi.org/10.1093/eurhea....
|
14. |
Shimbo D, Grahame-Clarke C, Miyake Y, Rodriguez C, Sciacca R, Di Tullio M, Boden-Albala B, Sacco R, Homma S. The association between endothelial dysfunction and cardiovascular outcomes in a population-based multi-ethnic cohort. Atherosclerosis. 2007;192(1):197-203. https://doi.org/10.1016/j.athe... PMid:16762358.
|
15. |
Kitakaze M, Asakura M, Kim J. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials. Lancet. 2007;27:1483–93. https://doi.org/10.1016/S0140-....
|
16. |
Sizova ZM, Zakharova VL, Shamieva ES, Kozlova NV. Possibilities of nicorandil in correction of the coronary reserve and endothelial dysfunction in patients with ischemic heart disease. Heart. 2013;2(70);12:75-81.
|
17. |
Sizova ZM, Kozlova NV, Zakharova VL, Shameeva ES. Comparative assessment of effects of isosorbide dinitrate, isosorbide-5-mononitrate and nicorandil on the frequency of angina attacks and endothelial vasoregulating function in patients with ischemic heart disease. Cardiology. 2015;2:10-15. https://doi.org/10.18565/cardi....
|
18. |
Martsevich SY, Kutishekno NP, Deev AD. Studying the effect of nicorandil on quality of life in patients with stable angina of effort within the framework of the KVAZAR study. Rational Pharmacotherapy in Cardiology. 2016;12(6):654-660. https://doi.org/10.20996/1819-....
|
19. |
Martsevich SY, LukinaYV, Kutishekno NP. An observational multicentre study of nicorandil in patients with stable ischaemic heart disease and high cardiovascular risk. Russian Cardiological Journal. 2017; :75-82. https://doi.org/10.15829/1560-....
|
20. |
Spertus JA, Winder JA, Dewhurst TA. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. J Am Coll Cardiol. 1995;25(2):333-341. https://doi.org/10.1016/0735-1....
|
21. |
Spertus JA, Winder JA, Dewhurst TA. Monitoring the quality of life in patients with coronary artery disease. Am J Cardiol.1994;74(12):1240-1254. https://doi.org/10.1016/0002-9....
|
22. |
Spertus JA, Jones P, McDonell M. Health status predicts long-term outcome in outpatients with coronary disease. Circulation.2002; 106(1):43-9. https://doi.org/10.1161/01.CIR....
|
23. |
Agarwal S, Schechter C, Zaman A. Assessment of functional status and quality of life after percutaneous coronary revascularisation in octogenarians. Age Ageing. 2009;38(6):748-51. https://doi.org/10.1093/ageing....
|
24. |
Seki S, Kato N, Ito N. Validity and reliability of Seattle angina questionnaire Japanese version in patients with coronary artery disease. Asian Nurs Res. 2010;4(2):57-63. https://doi.org/10.1016/S1976-....
|
25. |
Shore S, Smolderen KG, Kennedy KF. Health status outcomes in patients with acute myocardial infarction after rehospitalization. Circ Cardiovasc Qual Outcomes. 2016;9(6):777-84. https://doi.org/10.1161/CIRCOU....
|